“Healthcare and pharma are steadily moving past a TV-first mindset. While linear TV made up more than 30% of the industry’s ...

A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...

iSpot, the cross-platform video ad measurement company, has announced it will now support search signals as an option in its business attribution solutions suite through a newly formed partnership ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min She joins the company from ...

NEW YORK — Cross-platform TV advertising measurement company iSpot has named a new President and Chief Revenue Officer. It is a “strategic hire” for iSpot, which continues to seek to establish itself ...

BELLEVUE, Wash.—Julie Van Ullen has joined cross-platform TV ad measurement company iSpot as president and chief revenue officer. Van Ullen, who will report to iSpot founder and CEO Sean Muller, will ...

When the NFL decided to add commercials to RedZone Channel — which had long been advertised as “Seven hours of commercial-free football” — the spin from the league was that these commercials would be ...

Former President Barack Obama is featured in a new ad supporting California's Proposition 50 redistricting plan. The "Yes on 50" campaign, led by Gov. Gavin Newsom, is a response to Republican-led ...

BELLEVUE, Wash.—Despite ongoing worries about the economy, new data from iSpot shows that national linear advertising revenue recorded a 4.2% increase in Q3 2025 versus a year earlier to $8.77 billion ...

Starting July 1 of next year, Netflix and Co. will need to keep the audio levels consistent from movie and TV shows to advertisements. By Erik Hayden Executive Editor, Business In an effort to cut ...

One could argue that there are varying levels to the randomness. For example, Kevin Hart’s Verizon commercial may feel slightly more elevated and acceptable than, say, LeBron James’ Royal Kingdom ad. ...

Bausch Health and Teva Pharmaceuticals were sued on Monday for allegedly conspiring to delay sales of a generic version of Bausch’s blockbuster diarrhea drug Xifaxan, resulting in buyers paying ...